SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 145 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275,415 | -29.7% | 18,968 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $391,558 | +40.3% | 18,708 | +41.5% | 0.00% | 0.0% |
| Q1 2023 | $279,164 | -17.0% | 13,218 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $336,398 | +9.2% | 13,218 | +3.2% | 0.00% | 0.0% |
| Q3 2022 | $308,000 | +25.2% | 12,808 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $246,000 | +10.8% | 12,808 | +0.1% | 0.00% | – |
| Q1 2022 | $222,000 | -20.7% | 12,798 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $280,000 | +22.8% | 12,798 | +7.1% | 0.00% | – |
| Q3 2021 | $228,000 | +11.2% | 11,949 | 0.0% | 0.00% | – |
| Q2 2021 | $205,000 | -1.4% | 11,949 | +28.3% | 0.00% | – |
| Q1 2021 | $208,000 | +2.0% | 9,312 | +1.7% | 0.00% | – |
| Q4 2020 | $204,000 | – | 9,152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 956,165 | $20,930,000 | 11.19% |
| Aisling Capital Management LP | 1,025,000 | $22,437,000 | 7.92% |
| FRAZIER MANAGEMENT LLC | 2,772,062 | $60,680,000 | 4.67% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,176,585 | $25,755,000 | 2.83% |
| Paradigm Biocapital Advisors LP | 453,091 | $9,918,000 | 2.83% |
| Ghost Tree Capital, LLC | 300,000 | $6,567,000 | 2.35% |
| Avidity Partners Management LP | 4,823,400 | $105,584,000 | 2.24% |
| Nantahala Capital Management | 2,850,559 | $62,399,000 | 2.20% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $4,512,000 | 1.90% |
| BVF INC/IL | 2,099,714 | $45,963,000 | 1.67% |